In this research, the authors demonstrated that the full size of the ITI‐H4 protein was increased, while a fragment of ITI‐H4 was decreased in AD patients, and Cofilin 2, ApoA4, Tetranectin, AZGP1, and AMBP were significantly increased in AD patients. This evidence concerns the gene CFL2 and Alzheimer disease.